Similar companies
Income Statement (NONE)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 14.2B | 24.4% |
| Gross Profit | 10.1B | 122.3% |
| Cost of Revenue | 4.09B | 40.4% |
| Operating expense | 6.44B | 0.7% |
| Net Income | 2.82B | 152.9% |
| EBITDA | 4.25B | 109.6% |
Balance Sheet (NONE)
| Q3 '24 | QoQ | |
|---|---|---|
| Shares Outstanding | 1.26B | 0% |
Cash Flow (NONE)
| Q3 '24 | QoQ |
|---|
Financial Highlights for Sanofi in Q3 '24
Sanofi reported a revenue of 14.2B, which is a 24.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 10.1B, marking a 122.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 4.09B, a -40.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 6.44B, showing a 0.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 2.82B, showing a 152.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 4.25B, showing a 109.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Sanofi with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
